ArticleScientific reports2025
Evaluation of antioxidant, anticholinesterase and antiproliferative potential of Artemisia herba-alba by artificial intelligence-assisted extraction optimization.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Bioactivity assessment and LC-MS/MS-based phenolic characterization of Gypsophila pilosa.Scientific reports · 2026Article
- Artificial Intelligence Assisted Optimization ofMolecules (Basel, Switzerland) · 2026Article
- Evaluation of the phenolic profile and biological activities of Boletus speciosus extracts optimized with response surface methodology and artificial neural networks-genetic algorithm.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, in order to maximize the biological activity of Artemisia herba-alba Asso, extraction conditions were optimized by two different methods: Response Surface Methodology (RSM) and Artificial Neural Network-Genetic Algorithm (ANN-GA). A total of 27 experimental conditions were created by evaluating the parameters of extraction temperature (45, 55 and 65 °C), time (5, 10, 15 h) and ethanol/water ratio (0, 50, 100%) and the obtained data were applied to the optimization algorithms. ANN-GA method provided higher biological activity parameters compared to RSM. The TAS value of the extract obtained with ANN-GA was determined as 9.449 mmol/L, DPPH value as 150.673 mg TE/g, FRAP value as 226.580 mg TE/g, TPC value as 303.120 mg GAE/g and TFC value as 363.583 mg QE/g. In anticholinesterase activity tests, AChE IC₅₀ value of ANN-GA extract was 41.923 µg/mL, BChE IC₅₀ value was 61.450 µg/mL, and it showed a stronger inhibitory effect than RSM extract. In antiproliferative assays, both extracts demonstrated a dose-dependent reduction in cell viability on A549 (lung), MCF-7 (breast), and DU-145 (prostate) cancer cell lines. The strongest inhibitory effects were observed at 100 and 200 µg/mL concentrations. Although no statistically significant difference was found between the two methods, the RSM extract exhibited slightly greater antiproliferative efficacy across all three cell lines, particularly at higher con-centrations. These results indicate that both extraction approaches are effective in suppressing cancer cell proliferation, with the RSM method showing a marginal advantage in cytotoxic activity. In the phenolic compound analysis performed by LC-MS/MS, higher levels of pharmacologically important compounds such as naringenin (16,488.02 mg/kg), kaempferol (14,206.24 mg/kg), and caffeic acid (9291.10 mg/kg) were detected in ANN-GA extract. The results show that ANN-GA based optimization approach is an effective strategy to increase antioxidant, anticholinesterase and antiproliferative activities and support the pharmaceutical potential of A. herba-alba.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.